Market Cap : 8.11 B | Enterprise Value : 8.05 B | P/E (TTM) : | P/B : 73.70 |
---|
NAS:NVAX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:NVAX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Novavax's enterprise value is $8,048.8 Mil. Novavax's EBITDA for the trailing twelve months (TTM) ended in Sep. 2020 was $-255.3 Mil. Therefore, Novavax's EV-to-EBITDA for today is -31.53.
During the past 13 years, the highest EV-to-EBITDA of Novavax was -1.30. The lowest was -126.70. And the median was -7.40.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2021-01-19), Novavax's stock price is $127.430000. Novavax's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2020 was $-5.22. Therefore, Novavax's PE Ratio for today is .
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
* The bar in red indicates where Novavax's EV-to-EBITDA falls into.
Novavax's EV-to-EBITDA for today is calculated as:
EV-to-EBITDA | = | Enterprise Value (Today) | / | EBITDA (TTM) |
= | 8048.795 | / | -255.257 | |
= | -31.53 |
Novavax's current Enterprise Value is $8,048.8 Mil.
Novavax's EBITDA for the trailing twelve months (TTM) ended in Sep. 2020 was -27.851 (Dec. 2019 ) + -21.892 (Mar. 2020 ) + -13.494 (Jun. 2020 ) + -192.02 (Sep. 2020 ) = $-255.3 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Novavax's PE Ratio for today is calculated as:
PE Ratio | = | Share Price (Today) | / | Earnings per Share (Diluted) (TTM) |
= | 127.430000 | / | -5.22 | |
= |
Novavax's share price for today is $127.430000.
Novavax's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2020 was -1.13 (Dec. 2019 ) + -0.58 (Mar. 2020 ) + -0.3 (Jun. 2020 ) + -3.21 (Sep. 2020 ) = $-5.22.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Please read Which price ratio outperforms the enterprise multiple?
No Headline